Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.
RBL Bank Q4 Results: Profit soars 3x YoY to Rs 230 crore
RBL Bank reported a significant three-fold surge in net profit for the fourth quarter, reaching Rs 230 crore, driven by robust business expansion and improved